Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Kitchener
Clinical trial register · Canada

Clinical Trials in Kitchener, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6553 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:20 UTC
6553
Studies in scope
all four open statuses
3487
Recruiting now
open to new participants
880
Lead sponsors
across recruiting studies
Top sites
Toronto 2818 Montreal 1913 Vancouver 1187 Calgary 1068 Edmonton 1018
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca6 Canadian Cancer Trials Group6 National Cancer Institute (NCI)4 Pfizer3 Merck Sharp & Dohme LLC2 Ottawa Hospital Research Institute2 Gilead Sciences2 Boehringer Ingelheim1 NRG Oncology1 Hamilton Health Sciences Corporation1 Mark Vincent1 Centre hospitalier de l'Université de Montréal (CHUM)1 Unity Health Toronto1 ImmunityBio, Inc.1 Canadian Immunization Research Network1 Jonathan Vaisberg1 Radiation Therapy Oncology Group1 David Palma1 Australasian Gastro-Intestinal Trials Group1 University of Pittsburgh1 Taiho Oncology, Inc.1 Hyivy Health Inc1 Population Health Research Institute1 Habib Khan1 McGill University Health Centre/Research Institute of the McGill University Health Centre1 Heart Rhythm Clinical and Research Solutions, LLC1 Nova Scotia Health Authority1 Abbott Medical Devices1 McMaster University1 AtriCure, Inc.1 Otsuka Pharmaceutical Development & Commercialization, Inc.1
Site location
Toronto2818 Montreal1913 Vancouver1187 Calgary1068 Edmonton1018 Ottawa884 London878 Hamilton811 Québec682 Halifax535 Winnipeg454 Sherbrooke264 Kingston254 Kelowna176 Brampton143 Surrey138 Victoria129 St. John's126 Barrie125 Saskatoon125 Chicoutimi100 Moncton92 Mississauga89 Greater Sudbury83 Regina82 Trois-Rivières80 Saint John75 Greenfield Park73 Oshawa73 New Westminster70 Newmarket68 North York64 Markham61 Ajax60 Windsor55 Lévis53 Kitchener49 Fredericton49 Oakville48 Waterloo47 Guelph42 Rimouski39 Burlington37 Peterborough37 Abbotsford British Columbia36 Sarnia34 Red Deer33 Scarborough Village32 Laval30 Cambridge30 Richmond Hill30 Etobicoke26 Vaughan26 Thunder Bay26 Gatineau24 Prince George22 Sault Ste. Marie21 North Vancouver20 Richmond20 Burnaby19 Sherwood Park18 Lethbridge18 Verdun18 Whitby17 Niagara Falls17 North Bay17 Sydney16 St. Catharines14 Stouffville13 Saint-Jérôme13 Saint-Charles-Borromée13 Longueuil13 Stoney Creek12 Concord11 Kentville11 Truro10 Terrebonne10 Penticton10 Courtice9 Mount Royal9 Kamloops9 Mirabel8 Victoriaville8 St. Albert7 Saint Catharines7 Winchester7 Joliette6 Brandon6 Dartmouth6 West Vancouver6 Bridgewater6 Saguenay6 Medicine Hat6 Thornhill6 Brantford5 Pointe-Claire5 Orillia5 Westmount5 Cobourg5 East York5 Nanaimo5 Ontario5 Nova Scotia4 Owen Sound4 Chilliwack4 Montral4 North YORK4 Scarborough4 Boisbriand4 Multiple Locations4 Woodbridge4 Granby4 Langley4 Sainte-Foy4 New Minas3 Canmore3 Dieppe3 Ste-Foy3 Decarie Montreal3 Many Locations3 Grande Prairie3 Winnepeg3 Chatham2 Stratford2 Belleville2 Nepean2 Saint Johns2 Saint-Georges2 Fort McMurray2 Cranbrook2 Hawkesbury2 Dundas2 Sainte-Marie2 Okanagan2 SaintJerome2 Pembroke2 Pierrefonds2 Bedford2 Alberta2 Banff2 Jonquière2 Saint-Laurent2 Edmundston2 Montréal2 Niagara2 Hanover1 Renfrew1 Drummondville1 Maria1 Miramichi1 Penetanguishene1 Norway House1 Baie-Saint-Paul1 La Malbaie1 Edmonton & Calgary1 Multiple1 North Van Couver1 Grand Prairie1 Mississagua1 Saint Isidore1 Bowmanville1 Coxheath1 Lai Chi Kok1 Sioux Lookout1 Wawa1 Piikani Nation1 Flying Dust First Nation1 Ministikwan Lake1 Onion Lake1 Waterhen Lake1 Greenville1 Fleurimont1 Saint Catherines1 Prince Albert1 Calgery1 Frederiction1 Vancouver BC1 Prince Rupert1 Sept-Îles1 Ville-Marie1 Orangeville1 Whistler1 Egypt1 Port Perry1 Newcastle1 Mira Road1 Happy Valley-Goose Bay1 Norris Point1 Woodstock1 High River1 Antigonish Nova Scotia1 Saint Jerome Quebec1 Airdrie1 Burin1 Clarenville1 Hailfax1 Alliston1 Cowansville1 Saint-Hyacinthe1 Montr Al1 Kanata1 Pickering1 Columbia1 Charlottetown1 Dalhousie1 Carbonear1 Cornwall1 Limoges1 Orléans1 Aurora1 Mission1 Dorchester1 Smiths Crossing1 Moose Jaw1 Fort Erie1 Kelowna BC1 Coburg1 Tiny1 Ganges1 Bathurst1 Bouctouche1 Campbellton1 Caraquet1 Grand Falls1 Saint-Quentin1 Pierrefonds-Roxboro1 Edmonton AB1 Montréal1 Châteauguay1 Portage la Prairie1 Denver1 Winnipeg MB1 Brockville1 Montreal, Quebec1 Weston1 Gloucester1 Emo1 Dryden1 Fort Frances1 Lakefield1 Napanee1 Hamitlon1 Laurier1 Hagersville1 Strathroy1 West Hamilton1 Don Mills1 Val-d'Or1
All 248 locations
Target enrolment
to

Trials with a site in Kitchener

49 of 6553 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Recruiting
AstraZeneca
Phase 3
1,330
Calgary, Edmonton, Abbotsford British Columbia, Brampton, Kitchener, North York, Ottawa, Toronto
2026-09-15
Not yet open
Jonathan Vaisberg
Not applicable
25
Kitchener
2026-05-04
Recruiting
Ottawa Hospital Research Institute
Phase 4
50
Kitchener, Ottawa, Saskatoon
2026-02-02
Recruiting
Canadian Immunization Research Network
Not applicable
600
Halifax, Kitchener
2025-10-23
Recruiting
Canadian Cancer Trials Group
Phase 2
140
Calgary, Kelowna, Vancouver, Hamilton, Kingston, Kitchener, London, Mississauga
2025-10-21
Recruiting
ImmunityBio, Inc.
Phase 3
507
North Vancouver, Saint John, Brampton, Kitchener, London, Newmarket, Windsor
2025-10-01
Active, closed
Pfizer
Phase 1/2
74
Calgary, Kitchener
2025-06-30
Recruiting
Canadian Cancer Trials Group
Phase 3
830
Edmonton, Vancouver, Winnipeg, Saint John, Greater Sudbury, Hamilton, Kingston, Kitchener
2025-05-28
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Cambridge, Greater Sudbury, Hamilton, Kitchener, Mississauga, Oakville, Oshawa, Peterborough
2025-05-20
Recruiting
Feasibility of Hyivy Device Post-Radiation for Pelvic Malignancies
NCT05648253Vaginal Stenosis, Radiation Therapy, Cancer, Pelvic Pain
Hyivy Health Inc
Not applicable
12
Kitchener
2025-04-11
Recruiting
Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes
NCT06439225Metastatic Castration-resistant Prostate Cancer, Metastatic Prostate Cancer
DrugsDocetaxel·Carboplatin
Canadian Cancer Trials Group
Phase 3
236
Calgary, Edmonton, Vancouver, Brampton, Kitchener, London, Ottawa, Toronto
2024-12-30
Recruiting
McGill University Health Centre/Research Institute of the McGill University Health Centre
Not applicable
548
Edmonton, Abbotsford British Columbia, Mission, Dorchester, Smiths Crossing, Truro, Kingston, Kitchener
2024-10-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
550
Edmonton, Kitchener, Toronto, Montreal
2024-06-11
Recruiting
Merck Sharp & Dohme LLC
Phase 3
851
Kingston, Kitchener, Montreal, Trois-Rivières
2024-06-10
Recruiting
Canadian Cancer Trials Group
Phase 3
710
St. John's, Barrie, Kingston, Kitchener, London, Mississauga, Oshawa, Toronto
2024-04-25
Recruiting
RAFT - Pace &Ablate
NCT06299514Atrial Fibrillation, Heart Failure, Pacemaker, Arrhythmia Atrial
Habib Khan
Not applicable
600
Victoria, Halifax, Hamilton, Kitchener, London, Newmarket, Ottawa, Toronto
2024-04-25
Recruiting
Canadian Cancer Trials Group
Phase 2
168
Calgary, Vancouver, Winnipeg, Halifax, Barrie, Hamilton, Kingston, Kitchener
2024-04-16
Recruiting
AtriCure, Inc.
Observational
10,000
Halifax, Kitchener
2024-03-11
Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
NCT05987241Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma, Muscle Invasive Ureter Urothelial Carcinoma, Muscle Invasive Urethral Urothelial Carcinoma
DrugsRelatlimab·Opdivo·Nivolumab
National Cancer Institute (NCI)
Phase 2/3
992
Calgary, Edmonton, Vancouver, Kitchener, London, Ottawa, Toronto, Regina
2024-02-02
Recruiting
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism
Hamilton Health Sciences Corporation
Not applicable
4,000
Calgary, Vancouver, Winnipeg, Burlington, Cambridge, Hamilton, Kitchener, London
2023-11-30
Recruiting
NRG Oncology
Phase 3
3,960
Barrie, Kitchener, London, Oakville, Oshawa, Toronto, Montreal, Québec
2023-10-18
Recruiting
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
NCT05727176Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement
DrugFutibatinib
Taiho Oncology, Inc.
Phase 2
120
Toronto, Kitchener, Montreal
2023-07-05
Active, closed
Population Health Research Institute
Not applicable
5,100
Montreal, Brampton, Edmonton, Hamilton, Kingston, Kitchener, London, Newmarket
2023-06-22
Recruiting
Unity Health Toronto
Not applicable
580
Kitchener, Richmond Hill, Toronto, Whitby
2023-05-10
Active, closed
Pfizer
Phase 3
624
Edmonton, Surrey, Moncton, Kitchener, Toronto, Saint-Jérôme
2023-03-03
Active, closed
AstraZeneca
Phase 3
1,350
Saint John, Brampton, Greater Sudbury, Kitchener, Newmarket, Montreal, Saint-Jérôme, Saskatoon
2022-12-29
Active, closed
Gilead Sciences
Phase 3
443
Calgary, Edmonton, Halifax, Kitchener, London, Montreal, Ontario, Ottawa
2022-07-25
Active, closed
Gilead Sciences
Phase 3
623
Edmonton, Halifax, Kitchener, London, Montreal, Ottawa, Toronto
2022-07-20
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
Calgary, Hamilton, Kitchener, Oshawa, Scarborough Village, Toronto, Greenfield Park, Montreal
2022-03-15
Recruiting
Clarifying the Optimal Application of SLT Therapy Trial
NCT04967989Glaucoma and Ocular Hypertension
University of Pittsburgh
Phase 3
790
Kitchener
2021-09-07
Recruiting
Ottawa Hospital Research Institute
Phase 4
500
Edmonton, Kitchener, London, Markham, Ottawa, Thunder Bay, Regina, Saskatoon
2021-08-19
Active, closed
AstraZeneca
Phase 3
1,157
Calgary, Halifax, Barrie, Kitchener, Newmarket, North York, Toronto, Montreal
2021-04-26
Active, closed
AstraZeneca
Phase 3
1,371
Edmonton, Vancouver, Kitchener, London, Toronto, Montreal
2021-01-28
Recruiting
Mark Vincent
Phase 2
200
Vancouver, Brampton, Hamilton, Kitchener, London, Oshawa, Ottawa, Toronto
2021-01-06
Active, closed
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 3
800
Kelowna, Vancouver, Barrie, Hamilton, Kitchener, London, Toronto, Laval
2021-01-06
Recruiting
Canadian Cancer Trials Group
Phase 2
60
Edmonton, Kelowna, Vancouver, Saint John, Hamilton, Kitchener, Ottawa, Toronto
2020-03-09
Active, closed
SyncAV Post-Market Trial
NCT04100148Congestive Heart Failure
Abbott Medical Devices
Not applicable
1,686
Calgary, Vancouver, Victoria, Montreal, St. John's, Halifax, Kingston, Kitchener
2019-10-03
Active, closed
Reversal of Atrial Substrate to Prevent Atrial
NCT03682991Atrial Fibrillation
Nova Scotia Health Authority
Not applicable
509
Calgary, Edmonton, Kelowna, Vancouver, Saint John, Halifax, Hamilton, Kitchener
2019-07-01
Active, closed
AstraZeneca
Phase 3
923
Victoria, Kitchener, North York, Toronto
2019-06-25
Active, closed
David Palma
Phase 3
204
Victoria, Halifax, Greater Sudbury, Kitchener, London, Mississauga, St. Catharines, Toronto
2019-02-22
Active, closed
AstraZeneca
Phase 3
825
Edmonton, Kitchener, Lévis, Montreal, Québec, Saskatoon
2018-12-06
Recruiting
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
NCT04088071Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation, Ventricular Arrhythmia
Heart Rhythm Clinical and Research Solutions, LLC
Observational
20,000
Edmonton, Kitchener, Newmarket, Montreal
2018-01-01
Active, closed
Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
NCT02506153Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma, Metastatic Mucosal Melanoma
DrugsUrifron·Yervoy·Ipilimumab·Keytruda
National Cancer Institute (NCI)
Phase 3
1,301
Vancouver, Moncton, Barrie, Hamilton, Kingston, Kitchener, London, Mississauga
2015-11-10
Active, closed
McMaster University
Not applicable
5,000
Vancouver, Hamilton, Kingston, Kitchener, London, Niagara, Ottawa, Toronto
2015-10-21
Active, closed
Pfizer
Phase 3
1,068
Calgary, Edmonton, Vancouver, Winnipeg, Halifax, Barrie, Kingston, Kitchener
2014-12-17
Active, closed
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors
NCT01841736Foregut Neuroendocrine Tumor, Hindgut Neuroendocrine Tumor, Metastatic Digestive System Neuroendocrine Tumor G1, Metastatic Neuroendocrine Tumor
DrugPazopanib
National Cancer Institute (NCI)
Phase 2
171
Calgary, Vancouver, Moncton, Halifax, Hamilton, Kitchener, Ottawa, Toronto
2013-09-20
Active, closed
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
NCT01274338Melanoma of Unknown Primary, Recurrent Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7
DrugsUrifron·Yervoy·Ipilimumab
National Cancer Institute (NCI)
Phase 3
1,673
Edmonton, Winnipeg, Greater Sudbury, Kitchener, Ottawa, Toronto, Montreal
2011-06-17
Active, closed
Radiation Therapy Oncology Group
Phase 3
2,354
Edmonton, Vancouver, Winnipeg, Saint John, Kitchener, London, Newmarket, Ottawa
2011-05-24
Active, closed
Australasian Gastro-Intestinal Trials Group
Phase 2/3
574
Vancouver, Winnipeg, Barrie, Kingston, Kitchener, London, Ottawa, Toronto
2009-09
Rows per page Showing 1–49 of 49
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-canada/city/kitchener

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,553 studies in total at the last sync on 10 Nov 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 49 of those studies with a site in Kitchener.

How many clinical trials are recruiting in Kitchener?

25 of the 49 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:20 UTC sync. A further 1 have not yet opened recruitment, 23 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Kitchener), 49 studies
PhaseStudiesRecruitingShare
Phase 325951%
Not applicable11622.4%
Phase 26512.2%
Observational224.1%
Phase 2/3214.1%
Phase 4224.1%
Phase 1/2102%

Most active sponsors

Lead sponsors with the most studies (Kitchener)
Lead sponsorStudiesRecruiting
AstraZeneca61
Canadian Cancer Trials Group66
National Cancer Institute (NCI)41
Pfizer30
Gilead Sciences20
Merck Sharp & Dohme LLC21
Ottawa Hospital Research Institute22
Abbott Medical Devices10
AtriCure, Inc.11
Australasian Gastro-Intestinal Trials Group10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.